Advertisement

Loading...

Sernova Corp.

SVA.TOTSX
Healthcare
Biotechnology
$0.15
$0.00(0.00%)
Canadian Market is Open • 15:53

Sernova Corp. Fundamental Analysis

Sernova Corp. (SVA.TO) shows moderate financial fundamentals with a PE ratio of -4.35, profit margin of 0.00%, and ROE of 51.72%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

ROE51.72%
PEG Ratio-0.20

Areas of Concern

Operating Margin0.00%
Cash Position1.14%
Current Ratio0.03
We analyze SVA.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.0/100

We analyze SVA.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

SVA.TO struggles to generate sufficient returns from assets.

ROA > 10%
-12.23%

Valuation Score

Excellent

SVA.TO trades at attractive valuation levels.

PE < 25
-4.35
PEG Ratio < 2
-0.20

Growth Score

Moderate

SVA.TO shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
52.00%

Financial Health Score

Moderate

SVA.TO shows balanced financial health with some risks.

Debt/Equity < 1
-0.69
Current Ratio > 1
0.03

Profitability Score

Weak

SVA.TO struggles to sustain strong margins.

ROE > 15%
51.72%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is SVA.TO Expensive or Cheap?

P/E Ratio

SVA.TO trades at -4.35 times earnings. This suggests potential undervaluation.

-4.35

PEG Ratio

When adjusting for growth, SVA.TO's PEG of -0.20 indicates potential undervaluation.

-0.20

Price to Book

The market values Sernova Corp. at -2.10 times its book value. This may indicate undervaluation.

-2.10

EV/EBITDA

Enterprise value stands at -3.40 times EBITDA. This is generally considered low.

-3.40

How Well Does SVA.TO Make Money?

Net Profit Margin

For every $100 in sales, Sernova Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $51.72 in profit for every $100 of shareholder equity.

51.72%

ROA

Sernova Corp. generates $-12.23 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.23%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

SVA.TO converts -13.67% of its market value into free cash.

-13.67%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.35

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.20

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.10

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.69

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.52

vs 25 benchmark

ROA

Return on assets percentage

-12.23

vs 25 benchmark

ROCE

Return on capital employed

0.50

vs 25 benchmark

How SVA.TO Stacks Against Its Sector Peers

MetricSVA.TO ValueSector AveragePerformance
P/E Ratio-4.3527.91 Better (Cheaper)
ROE51.72%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity-0.690.33 Strong (Low Leverage)
Current Ratio0.032795.76 Weak Liquidity
ROA-1222.58%-13557.00% (disorted) Weak

SVA.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sernova Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-74.96%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-66.41%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ